Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: determined (252), resolute (3)

Osimertinib

Description: Chemotherapy Protocol Lung cancer - Non-small cell (NSCLC) OSIMERTINIB Regimen • NSCLC - Osimertinib Indication • Osimertinib is available as
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Osimertinib.pdf

Temsirolimus v1.1

Description: Chemotherapy Protocol RENAL CELL TEMSIROLIMUS This protocol may require funding Regimen Renal Cell - Temsirolimus Indication First li
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Temsirolimus-v1.1.pdf

Rituximab SC (8 weekly) Ver 1

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (8 weekly) Regimen Lymphoma – Rituximab SC (8 weekly) Indication Maintenance singl
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-8-weekly-Ver-1.pdf

Rituximab SC (12 weekly) Ver1

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (12 weekly) Regimen Lymphoma – Rituximab SC (12 weekly) Indication Maintenance sin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-12-weekly-Ver1.pdf

Rituximab (8 weekly)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB (8 Weekly) Regimen Lymphoma – Rituximab (8 weekly) Indication Non-Hodgkin’s Lymphoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-8-weekly.pdf

Rituximab (12 weekly)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB (12 weekly) Regimen Lymphoma – Rituximab (12 Weekly) Indication Non- Hodgkin’s Lympho
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-12-weekly.pdf

Paclitaxel (14day)

Description: Chemotherapy Protocol SARCOMA PACLITAXEL (14 day) Regimen • Sarcoma – Paclitaxel (14 day) Indication • Second line treatment of Kaposi sarcoma • WHO Performance status
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Paclitaxel14day.pdf

Carboplatin AUC2-RT

Description: Chemotherapy Protocol HEAD AND NECK CANCER CARBOPLATIN (AUC2)-RADIOTHERAPY Regimen • Head and Neck Cancer – Carboplatin(AUC2)-Radiotherapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Carboplatin-AUC2RT.pdf

Carboplatin AUC1.5+RT

Description: Chemotherapy Protocol HEAD AND NECK CANCER CARBOPLATIN (AUC1.5)-RADIOTHERAPY Regimen • Head and Neck Cancer – Carboplatin(AUC1.5)-Radiothe
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Carboplatin-AUC1.5RT.pdf

Lomustine-Procarbazine ver 1.1

Description: Chemotherapy Protocol Central Nervous System LOMUSTINE-PROCARBAZINE Regimen CNS – Lomustine-Procarbazine Indication Adjuvant treat
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Lomustine-Procarbazine-ver-1.1.pdf

351 to 360 of 496

Previous … 34 35 36 37 38 … Next